Genotype and pulmonary function in children with primary ciliary dyskinesia: a cross-sectional cohort study


Ünlü A., Soydaş Ş. S. A., Tabakçı S. Ö., Bilgiç I., Çakar M. K., Dinç G. A., ...Daha Fazla

European Journal of Pediatrics, cilt.185, sa.11, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 185 Sayı: 11
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1007/s00431-026-07574-2
  • Dergi Adı: European Journal of Pediatrics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
  • Anahtar Kelimeler: CCDC39, CCDC40, CCNO, DNAH11, Genotype–phenotype, Lung function, Pediatric, Primary ciliary dyskinesia
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet

Özet

Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder with variable clinical severity. Genotype-associated differences in pulmonary function remain incompletely characterized, particularly in exclusively pediatric cohorts. This retrospective cross-sectional study included 44 children with molecularly confirmed PCD based on biallelic pathogenic or likely pathogenic variants. Clinical characteristics and spirometric parameters were compared across genotype-based groups. Exploratory gene-level comparisons were performed for the most frequently represented genotypes. Multivariable linear regression assessed associations between DNAH5, DNAH11, and CCDC39/CCDC40 and FEV1 z-score after adjustment for age at diagnosis, BMI z-score, and bronchiectasis. The median age at diagnosis was 8.7 years (IQR 6–13), and parental consanguinity was present in 59.1% of patients. DNAH5 was the most frequently identified gene (22.7%), followed by DNAH11 and CCNO (13.6% each). FEV1% predicted, FEV1 Z-score, FVC Z-score, FEF25–75, FEF25–75% predicted, and FEV1/FVC differed significantly across the genotype-based groups (all p < 0.05), with the DNAH11 group showing the most preserved pulmonary function profile. In exploratory gene-level analyses, patients with CCNO and CCDC39/CCDC40 variants demonstrated numerically lower spirometric values, whereas DNAH11 showed the most preserved values and DNAH5 an intermediate profile. In exploratory adjusted analyses, CCDC39/CCDC40 was associated with lower FEV1 z-scores (B =− 1.55, p = 0.002), whereas DNAH11 was associated with higher FEV1 z-scores (B = 1.19, p = 0.023). Neither DNAH5 nor CCNO was independently associated with FEV1 z-score. Conclusion: Pulmonary function showed genotype-associated heterogeneity in this exclusively pediatric cohort with molecularly confirmed PCD. However, the gene-level findings remain exploratory because of the small subgroup sizes. Larger longitudinal multicenter studies are needed to confirm these associations. (Table presented.)